Key result
A 16-variable clinical and biomarker risk model predicted incident heart failure after myocardial infarction with modest discrimination (hold-out C-index 0.67, 95% CI 0.63-0.71).
Why the study?
Individuals with prior MI have an increased risk of HF, but current risk prediction models leave room for improvement.
Does a clinical and biomarker-based risk prediction model accurately predict incident heart failure in men and women with a history of myocardial infarction?
Cohort (n=4,743)
Yes
Does a clinical and biomarker-based risk prediction model accurately predict incident heart failure in men and women with a history of myocardial infarction?
This study identifies accessible haematological and renal blood biomarkers (including cystatin C, haemoglobin, mean reticulocyte volume, neutrophil percentage, and monocyte count) alongside clinical factors that independently predict long-term incident heart failure in post-MI patients with modest discrimination.
AIMS: Individuals with prior myocardial infarction (MI) show increased risk of heart failure (HF), yet current risk prediction models leave room for improvement. We aimed to develop and validate a clinically viable prediction model for incident HF in persons with prevalent MI in a general population, and explore sex- and MI subtype-specific differences. METHODS: We analysed UK Biobank participants with prior MI but absence of HF at baseline. Sociodemographic factors, clinical variables, and 59 blood biomarkers were included. The primary endpoint was the first in-hospital HF diagnosis. Backward selected Cox proportional hazards models were used to identify independent predictors of incident HF. Model performance was assessed via discrimination (C-index), using internal- and hold-out validation, and calibration. RESULTS: A total of 4,743 participants with prevalent MI; 81.4% male, median (P25-P75) age 62(58-66) years, were included. During a median follow-up of 12.1(11.1-13.0) years, 767(16.2%) developed HF. Sixteen independent predictors were identified and eleven remained significant (P<0.05) after treating all-cause mortality as a competing risk. These included several well-established predictors (age, body mass index, smoking, atrial fibrillation, diabetes) as well as haemoglobin (HR per 1 standard deviation (SD) increase: 0.88(95%CI:0.79-0.96)), mean reticulocyte volume (HR: (1.13(95%CI:1.03-1.23)), and neutrophil percentage (HR:1.12(95%CI:1.03-1.21)), monocyte count (HR:1.11(95%CI,1.06-1.16)). A trend towards an interaction(P<0.1) between sex and MI subtype was present. Model discrimination was modest (C-index=0.67) and calibration was adequate. CONCLUSION: Our study identifies several clinically accessible blood biomarkers as important risk factors for HF in post-MI individuals, and suggests interactions between sex and MI subtype. Further model refinement and external validation are needed.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2026) conducted a cohort in History of Myocardial Infarction (n=4,743). Clinical and blood biomarker risk prediction model (16 predictors) vs. Pooled Cohort Equations to Prevent Heart Failure (PCP-HF) score was evaluated on First in-hospital diagnosis of incident heart failure (ICD-10 code I50) (C-index 0.67, 95% CI 0.63-0.71). A 16-variable clinical and biomarker risk model predicted incident heart failure after myocardial infarction with modest discrimination (hold-out C-index 0.67, 95% CI 0.63-0.71).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: